With the recent COVID-19 pandemic, quantitative polymerase chain reaction (qPCR) was adopted rapidly into clinical and point-of-care testing laboratories enabling prompt diagnostics, treatment and surveillance. qPCR remains the go-to method for microbial detection in areas including clinical, agricultural, veterinary and food safety diagnostics.

This exclusive Ask Me Anything session delves into the cutting-edge advancements and international policy changes driving sustainability in the laboratory.

This AMA event grants you unprecedented access to the pioneering expert Dr. Nigel Jamieson, delving deep into the captivating realm of spatial biology – completely free of charge.

Advances in molecular and immunodiagnostics are enabling a personalized, high-precision approach to health in many clinical areas. But how will this continue to develop in the next five years?
In this webinar, our panel of industry experts will share insights on the molecular and immunodiagnostics market by looking at the external factors which will have the most significant impact in the next five years.
Our panel will also discuss the key challenges and opportunities facing the diagnostic industry and the developments that are likely to have the most impact on patients.

This exclusive AMA event grants you unprecedented access to the pioneering expert Prof. Michael Snyder a distinguished professor at Stanford University known for his ground-breaking work in digitalizing scientific research in the genomics and personalized medicine field.

When designing molecular diagnostic tests, different parameters are of interest to evaluate, for example, sensitivity, specificity, dynamic range, turnaround time and user friendliness. Which parameters are most important depends on application and may require extensive optimization. Examples will be discussed based on quantitative real-time PCR (qPCR) and digital PCR (dPCR).